-
-
Product Center
-
Application Fields
-
-
Contact Us
Application areas
Application area
Pharmaceutical Wastewater Treatment
According to incomplete statistics, China's pharmaceutical industry discharges 200 to 300 million tons of wastewater annually. Pharmaceutical wastewater contains a large amount of refractory organic pollutants, many of which have certain toxicity and "three causes" effects (carcinogenic, mutagenic, and teratogenic). If not treated adequately, these pollutants can affect the ecological balance and subsequently impact human health and survival.
Pharmaceutical wastewater contains a large amount of suspended solids. Through the high-efficiency separation of membrane, the suspended solids and turbidity in the water are reduced to near zero. Additionally, due to the presence of toxic substances in the wastewater, sludge expansion is likely to occur. Under membrane separation, the quality of the effluent is not affected. Moreover, the quality and quantity of pharmaceutical wastewater are highly variable. The high-efficiency retention of membrane increases sludge concentration, enhances the treatment capacity of the reactor, and allows it to withstand higher shock loads. From domestic engineering examples using Flat sheet membrane MBR technology for pharmaceutical wastewater treatment, the operating systems are generally stable, with good effluent quality, and a significant portion of wastewater has been recycled, saving investment for enterprises and achieving a win-win situation for economic and environmental benefits.
Existing engineering practices have shown that the Go Higher ‘s Flat sheet membrane MBR system has the following advantages in pharmaceutical wastewater treatment:
(1) High separation efficiency ensures the quality of the effluent. Pharmaceutical wastewater contains harmful substances that can easily cause sludge expansion. Under membrane separation, the quality of the effluent is not affected.
(2) High sludge concentration and strong biochemical capacity. Due to the significant variability in the quality and quantity of pharmaceutical wastewater, the increase in sludge concentration enhances the treatment capacity of the reactor and allows it to withstand higher shock loads.
(3) Improved purification efficiency for refractory organic matter. Refractory organic matter in pharmaceutical wastewater is retained within the reactor, which is conducive to the cultivation of certain specialized microorganisms.
(4) Favorable for the growth of nitrifying bacteria, with good NH3-N removal effects.
Contact:
Main Address: Jiahua Building, Zhongguancun Science Park, Beijing, China
Factory address:Beijing Economic and Technological Development Zone
Main Office: +86 10 62980139
Fax: +86 10 62981418
Tel：+86 10 153 0133 0853
office(US)：+1 919 666 7251
E-mail:ghm@gohigher.cn
Website:http://en.gohigher-m.cn